Startups
Edit
Animas® Insulin Pumps & Glucose Management Systems
http://www.animas.com/Last activity: 12.09.2016
Active
Overview
Location
United States, Pennsylvania, West Chester
Employees
1-10
Founded date
1996
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 13, 2013 | From inhalable insulin to vaccines: 5 diabetes companies to watch | Then there’s Pepex Biomedical, which is developing a line of all-in-one blood glucose meters that use biosensors and eliminate the need for testing strips. It’s also working on turning the technology into a cartridge that attaches to a smar... |
| Dec 20, 2011 | Aspire Bariatrics raises $16 million | Crothall has also served as a principal at Liberty Venture Partners, a Philadelphia venture capital firm focused on medical technology and IT companies. She also founded and served as CEO of Animas Corp., a manufacturer of insulin infusion ... |
| Mar 9, 2011 | Johnson & Johnson recalls nearly 400,000 Animas insulin cartridges | Johnson & Johnson (NYSE:JNJ) is recalling nearly 400,000 insulin cartridges made by its Animas subsidary because of the risk that they might leak insulin. Animas sent out a letter to patients Feb. 24 detailing the recall, saying "s... |
| Details scant, but Verily-Sanofi’s $500M diabetes JV aims to change behavior | $248 million in cash from Sanofi, and the same amount in a capital contribution by Verily (not in cash) have breathed life to a new company — Onduo — where the two equal partners will wage battle with a formidable enemy: diabetes. That part... | |
| Aspire Bariatrics raises $16 million | Aspire Bariatrics, a King of Prussia-based medical device company focused on weight loss, has raised $16.2 million of a $20 million target through a combination of equity, warrants and options, according to a filing with the U.S. Securities... | |
| From inhalable insulin to vaccines: 5 diabetes companies to watch | With an estimated 370 million people expected to have diabetes by 2030, the already $41 million market for diabetes management products is set to skyrocket over the next several years. Fittingly, creating devices, drugs and services aimed a... |
Reviews 0
FAQ about Animas® Insulin Pumps & Glucose Management Systems
When was Animas® Insulin Pumps & Glucose Management Systems founded?
Animas® Insulin Pumps & Glucose Management Systems was founded in 1996.
What has the press written about Animas® Insulin Pumps & Glucose Management Systems?
Parsers VC has collected 7 articles mentioning Animas® Insulin Pumps & Glucose Management Systems, among them “From inhalable insulin to vaccines: 5 diabetes companies to watch” (Aug 13, 2013) and “Aspire Bariatrics raises $16 million” (Dec 20, 2011).
Is Animas® Insulin Pumps & Glucose Management Systems still active?
Yes, Animas® Insulin Pumps & Glucose Management Systems is active; its latest activity on Parsers VC dates from Sep 12, 2016.